Cochlear valuation analysis FY26

Cochlear Ltd (COH.ASX) experienced a significant valuation reset during the fiscal year ending July 2026 Verified Answer #1. The company's share price declined by approximately 64%, falling from levels above AUD 319 to a closing price of AUD 111.61 on July 24, 2026 Verified Answer #1. This performance indicates a shift in market narrative from "defensive growth" to a reassessment of the company's cyclical exposure Verified Answer #1.

Primary Drivers of Price Depreciation

The downward price movement was primarily catalyzed by an earnings downgrade announced on April 22, 2026 Verified Answer #1. Cochlear lowered its FY2026 underlying net profit (NPAT) guidance from an initial range of AUD 435–460 million to AUD 290–330 million, representing a 30% reduction at the midpoint Verified Answer #1.

Several factors contributed to this depreciation Verified Answer #1:

Market Sentiment and Valuation

Technical indicators, including the Relative Strength Index (RSI), suggested the stock reached extreme oversold levels during the initial selloff in April 2026 Verified Answer #1. However, by late July 2026, market sentiment indicated that the stock had undergone a fundamental re-rating rather than a simple technical bounce Verified Answer #1. The market is currently recalibrating valuation multiples to reflect structural cyclicality and lower long-term margin assumptions Verified Answer #1. As of July 2026, the stock is described as being in a state of "valuation anchoring" Verified Answer #1.